Evaluating new vaccines and monoclonal antibodies for infectious diseases
NIAID - VRC - Pre-Clinical Assessment of monoclonal antibodies and other promising vaccines/agents
This study is working on creating new vaccines and treatments to help protect people from serious infections like HIV, Ebola, Zika, and Malaria, so that in the future, patients can have better options for staying healthy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Leidos Biomedical Research, INC. NIH-funded |
| Lab location | 1 site (Frederick, United States) |
| Project ID | NIH-10722428 on NIH RePORTER |
What this research studies
This research focuses on developing and testing new vaccines and monoclonal antibodies to combat infectious diseases that pose significant public health threats, such as HIV, Ebola, Zika, and Malaria. The approach involves pre-clinical assessments to evaluate the effectiveness and safety of these potential treatments before they are tested in humans. Patients may benefit from advancements in therapies that could provide better protection or treatment against these diseases.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit are individuals at risk for or affected by infectious diseases like HIV, Ebola, Zika, or Malaria.
Not a fit: Patients with non-infectious diseases or those not at risk for the targeted infectious diseases may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective vaccines and treatments for serious infectious diseases, improving patient outcomes and public health.
How similar studies have performed: Previous research has shown success in developing effective vaccines and monoclonal antibodies for infectious diseases, indicating a promising approach.
Where this research is happening
Frederick, United States
- Leidos Biomedical Research, INC. — Frederick, United States (Active)
Researchers
- Principal investigator: Case, Christopher — Leidos Biomedical Research, INC.
- Study coordinator: Case, Christopher
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.